ClinicalTrials.Veeva

Menu

The Osteoarticular Manifestations in Patients With Gitelman Syndrome (CPPD and more)

Zhejiang University logo

Zhejiang University

Status

Enrolling

Conditions

CPPD - Calcium Pyrophosphate Deposition Disease
Gitelman Syndrome

Treatments

Diagnostic Test: conventional radiograph or computed tomography

Study type

Observational

Funder types

Other

Identifiers

NCT06922370
2021-0670

Details and patient eligibility

About

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.

Full description

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed to investigate the osteoarticular features in patients with Gitelman Syndrome.

Enrollment

120 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients confirmed with Gitelman Syndrome

Exclusion criteria

  • Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism

Trial design

120 participants in 1 patient group

Patients with Gitelman Syndrome
Description:
Patients with clinically and genetically confirmed Gitelman syndrome.
Treatment:
Diagnostic Test: conventional radiograph or computed tomography

Trial contacts and locations

1

Loading...

Central trial contact

Lijun Mou

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems